ACTRN12611001038987尚未招募1 期
Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-929075 in Healthy Subjects.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 49 Years（—）
- 性别
- All
入选标准
- •Healthy men and women ages 18 to 49
- •Body Mass Index (BMI) of 18 to 32kg/m2
排除标准
- •Any significant acute or chronic medical illness, including any:
- •- liver disease with laboratory screening results for ALT, AST or bilirubin > upper limit of normal
- •- gastrointestinal disease within the past 3 months.
- •Any major surgery, donation of blood or plasma to a blood bank or receipt of a blood transfusion within the past 4 weeks.
- •Smoking more than 10 cigarettes per day.
- •Healthy subjects with any of the following ECG findings prior to dosing:
- •- PR>/= 210 msec
- •- QRS>/= 120 msec
- •- QT>/= 500 msec
- •- QTcF>/+ 450 msec
- •Positive urine screen for drugs of abuse or positive screen for Hepatitis C, Hepatitis B or HIV.
研究者
相似试验
已完成
1 期
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KER-047 Administered to Healthy Male Volunteers and Postmenopausal Female VolunteersMusculoskeletal - Other muscular and skeletal disordersFibrodysplasia ossificans progressivaACTRN12619000319178Keros Therapeutics, Australia Pty Ltd131
已完成
不适用
Randomised, double-blind, placebo-controlled, single-dose, dose-escalation study of the safety, tolerability, and pharmacokinetics of Lu AA24493 in acute ischemic strokeischemic stroke10007963NL-OMON31272undbeck5
尚未招募
2 期
Safety, tolerability and pharmacokinetics of SSTK-101 in healthy volunteersACTRN12624001064594SKYDD Biotechnology Pty Ltd38
进行中（未招募）
1 期
Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMSEUCTR2016-003139-39-ESSpherium Biomed
进行中（未招募）
1 期
Influenza virus challenge study to test monocloncal antibody CT-P27 as a treatment for influenza (flu)MedDRA version: 16.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsInfluenzaEUCTR2013-004544-32-GBCelltrion, Inc